Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 6/24/2019 9:00:01 PM
Instead of looking for missing books in your genetic library, #exome sequencing scans the pages for spelling mistak…
BCH Innovation News @BCH_Innovation 6/24/2019 7:00:01 PM
The deepest dive yet into recessive mutations in #autism, thanks to support from @NIH @SFARIorg @NIMHgov @NICHD_NIH…
BCH Innovation News @BCH_Innovation 6/24/2019 5:30:01 PM
Study including >2300 people with #autism, via Autism Sequencing Consortium, implicates new genes:…
BCH Innovation News @BCH_Innovation 6/24/2019 12:30:01 PM
A large, in-depth study identifies recessive #autism mutations that completely knock out a gene, explaining another…
BCH Innovation News @BCH_Innovation 6/21/2019 9:30:01 PM
Doubling down on double hits: Rare recessive mutations pry open new windows on #autismspectrumdisorder:…
BCH Innovation News @BCH_Innovation 6/21/2019 8:00:01 PM
Standing room only Senate hearing this week with our own David Williams, MD, advocating to make gene therapy and ot…
At Boston Children’s Hospital we build on our extraordinary leadership in pediatric science to translate daily our findings and those of others and fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer